BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 19770495)

  • 1. New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals.
    Beresford MW; Baildam EM
    Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):151-6. PubMed ID: 19770495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.
    Beresford MW; Baildam EM
    Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):144-50. PubMed ID: 19770494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile idiopathic arthritis--current and future therapies.
    Kahn P
    Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on biologics in juvenile idiopathic arthritis.
    Ilowite NT
    Curr Opin Rheumatol; 2008 Sep; 20(5):613-8. PubMed ID: 18698187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.
    Tynjälä P; Vähäsalo P; Honkanen V; Lahdenne P
    Ann Rheum Dis; 2009 Apr; 68(4):552-7. PubMed ID: 18467515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical treatment of juvenile idiopathic arthritis].
    Horneff G; Augustin S
    Med Monatsschr Pharm; 2008 Sep; 31(9):326-36; quiz 337-8. PubMed ID: 18831464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register.
    Otten MH; Prince FH; Anink J; Ten Cate R; Hoppenreijs EP; Armbrust W; Koopman-Keemink Y; van Pelt PA; Kamphuis S; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
    Ann Rheum Dis; 2013 May; 72(5):721-7. PubMed ID: 22730374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on biologicals for treatment of juvenile idiopathic arthritis.
    Horneff G
    Expert Opin Biol Ther; 2013 Mar; 13(3):361-76. PubMed ID: 23289865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile idiopathic arthritis: state of the art and future perspectives.
    Martini A; Lovell DJ
    Ann Rheum Dis; 2010 Jul; 69(7):1260-3. PubMed ID: 20525835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic therapies in juvenile idiopathic arthritis: why and for whom?
    McCann LJ; Woo P
    Acta Reumatol Port; 2007; 32(1):15-26. PubMed ID: 17450761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
    Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines for prescribing and monitoring biologic therapies in juvenile idiopathic arthritis].
    Santos MJ; Fonseca JE; Canhão H; Conde M; José Vieira M; Costa L; Costa M; Salgado M; Melo Gomes JA;
    Acta Reumatol Port; 2007; 32(1):43-7. PubMed ID: 17450764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile idiopathic arthritis.
    Borchers AT; Selmi C; Cheema G; Keen CL; Shoenfeld Y; Gershwin ME
    Autoimmun Rev; 2006 Apr; 5(4):279-98. PubMed ID: 16697970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile idiopathic arthritis - an update on pharmacotherapy.
    Kahn P
    Bull NYU Hosp Jt Dis; 2011; 69(3):264-76. PubMed ID: 22035441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on treatment of arthritis in children: new treatments, new goals.
    Lovell DJ
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):72-6. PubMed ID: 17121494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile idiopathic arthritis: an update.
    Olson JC
    WMJ; 2003; 102(7):45-50. PubMed ID: 14711024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment.
    Kanakoudi-Tsakalidou F; Tzimouli V; Pratsidou-Gertsi P; Chronopoulou E; Trachana M
    Cytokine; 2008 Jun; 42(3):293-7. PubMed ID: 18445529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile idiopathic arthritis.
    Weiss JE; Ilowite NT
    Pediatr Clin North Am; 2005 Apr; 52(2):413-42, vi. PubMed ID: 15820374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical treatment of juvenile idiopathic arthritis].
    Kröger L; Vähäsalo P; Tynjälä P; Aalto K; Säilä H; Malin M; Putto-Laurila A; Lahdenne P
    Duodecim; 2012; 128(5):477-86. PubMed ID: 22486063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Juvenile idiopathic arthritis].
    Herlin T
    Ugeskr Laeger; 2002 Aug; 164(34):3941-6. PubMed ID: 12212473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.